Skip to main content
. 2020 Nov 7;18:107. doi: 10.1186/s12958-020-00661-5

Fig. 4.

Fig. 4

Western blotting validation of differentially expressed proteins. a Verification of the expression of HLA-A and HLA-DRB1 in the control group and NMDAR-E group by western blotting analysis. The full-length blots are presented in Supplementary Fig. 4. b Quantitative assessment of protein expression using densitometric analysis. Four teratoma patients without NMDAR-E were in the control group (C-01 to 04), and 4 teratoma patients with NMDAR-E were in the NMDAR-E group (S-01 to 04). Data are represented as the mean ± SD. *P < .05